🔴 Cue Biopharma is trading 5.2% down today following its reverse split and private placement

Cue Biopharma is trading at $29.32 (5.2% down) as investors digest recent capital structure changes, including a reverse stock split and a private placement.

• The company recently completed a 1-for-30 reverse stock split and a $50 million private placement, which has significantly reduced the public float.
• Heightened volatility has followed an initial post-split price surge, driven by investor concerns regarding potential dilution from the new capital raise.